{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:53:18Z","timestamp":1787755998182,"version":"build-2784847793"},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.nec.2023.02.014","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T15:31:05Z","timestamp":1681140665000},"page":"479-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Modeling Meningiomas"],"prefix":"10.1016","volume":"34","author":[{"given":"Majid","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwin","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lucke-Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Karsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nec.2023.02.014_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/B978-0-12-804280-9.00008-1","article-title":"Preclinical models of meningioma: cell culture and animal systems","volume":"169","author":"Choudhury","year":"2020","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib2","first-page":"vdab085","article-title":"The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma","volume":"3","author":"Horbinski","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib3","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/cancers12061478","article-title":"Patient-derived orthotopic xenograft (PDOX) mouse models of primary and recurrent meningioma","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.nec.2023.02.014_bib4","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.3390\/cancers13153712","article-title":"Mouse models in meningioma research: a systematic review","volume":"13","author":"Boetto","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11060-010-0331-5","article-title":"Meningioma mouse models","volume":"99","author":"Kalamarides","year":"2010","journal-title":"J\u00a0Neuro Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.nec.2023.02.014_bib6","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","article-title":"Molecular and translational advances in meningiomas","volume":"21","author":"Suppiah","year":"2019","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/biomedicines6030086","article-title":"Emerging medical treatments for meningioma in the molecular era","volume":"6","author":"Nigim","year":"2018","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/CCO.0b013e3283571a06","article-title":"New insights into meningioma: from genetics to trials","volume":"24","author":"Vranic","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.nec.2023.02.014_bib9","doi-asserted-by":"crossref","first-page":"105947","DOI":"10.1016\/j.clineuro.2020.105947","article-title":"Prediction value of preoperative findings on meningioma grading using artificial neural network","volume":"196","author":"Khayat Kashani","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"10.1016\/j.nec.2023.02.014_bib10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/labinvest.3700307","article-title":"Establishment of a benign meningioma cell line by hTERT-mediated immortalization","volume":"85","author":"Puttmann","year":"2005","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib11","doi-asserted-by":"crossref","first-page":"e0178322","DOI":"10.1371\/journal.pone.0178322","article-title":"Genomic profile of human meningioma cell lines","volume":"12","author":"Mei","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-005-9076-y","article-title":"A\u00a0genetic strategy to overcome the senescence of primary meningioma cell cultures","volume":"78","author":"Baia","year":"2006","journal-title":"J\u00a0Neuro Oncol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1227\/01.NEU.0000255397.00410.8F","article-title":"Establishment of an in\u00a0vivo meningioma model with human telomerase reverse transcriptase","volume":"60","author":"Cargioli","year":"2007","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","article-title":"Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee","volume":"27","author":"Lee","year":"1990","journal-title":"Neurosurgery."},{"key":"10.1016\/j.nec.2023.02.014_bib15","doi-asserted-by":"crossref","first-page":"109141","DOI":"10.1016\/j.jneumeth.2021.109141","article-title":"Crispr\/Cas-based modeling of NF2 loss in meningioma cells","volume":"356","author":"Waldt","year":"2021","journal-title":"J\u00a0Neurosci Methods"},{"issue":"13","key":"10.1016\/j.nec.2023.02.014_bib16","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1038\/sj.onc.1202531","article-title":"NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas","volume":"18","author":"Leone","year":"1999","journal-title":"Oncogene"},{"issue":"36","key":"10.1016\/j.nec.2023.02.014_bib17","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1038\/onc.2012.436","article-title":"Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation","volume":"32","author":"Peyre","year":"2013","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.nec.2023.02.014_bib18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1593\/neo.08642","article-title":"The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP","volume":"10","author":"Striedinger","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.nec.2023.02.014_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jneumeth.2018.11.003","article-title":"In\u00a0vitro assessment of radiobiology of meningioma: a pilot study","volume":"311","author":"Pinzi","year":"2019","journal-title":"J\u00a0Neurosci Methods"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00002826-199619060-00006","article-title":"In\u00a0vitro chemotherapy of steroid receptor positive human meningioma low-passage primary cultures with nitrosourea-methionine-steroid conjugates","volume":"19","author":"Taut","year":"1996","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib21","first-page":"155","article-title":"[Chemosensitivity of cultured meningiomas]","volume":"8","author":"Tsuchida","year":"1995","journal-title":"Hum Cell"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/0008-5472.CAN-04-0786","article-title":"Induction of apoptosis in primary meningioma cultures by fenretinide","volume":"65","author":"Puduvalli","year":"2005","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.nec.2023.02.014_bib23","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1002\/cncr.27460","article-title":"Trabectedin has promising antineoplastic activity in high-grade meningioma","volume":"118","author":"Preusser","year":"2012","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.nec.2023.02.014_bib24","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.3390\/cancers13235898","article-title":"Receptor-tyrosine kinase inhibitor ponatinib inhibits meningioma growth in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Yu","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.nec.2023.02.014_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ejca.2012.01.032","article-title":"Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells","volume":"48","author":"Andrae","year":"2012","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cncr.22441","article-title":"Celecoxib inhibits meningioma tumor growth in a mouse xenograft model","volume":"109","author":"Ragel","year":"2007","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.nec.2023.02.014_bib27","doi-asserted-by":"crossref","first-page":"e130688","DOI":"10.1172\/jci.insight.130688","article-title":"Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK","volume":"4","author":"Giles","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11523-019-00654-4","article-title":"A\u00a0monoclonal antibody against beta1 integrin inhibits proliferation and increases survival in an orthotopic model of high-grade meningioma","volume":"14","author":"Nigim","year":"2019","journal-title":"Target Oncol"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1012941202510","article-title":"Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas","volume":"55","author":"Konstantinidou","year":"2001","journal-title":"J\u00a0Neuro Oncol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/cas.15221","article-title":"Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma","volume":"113","author":"Nakano","year":"2022","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0404.1987.tb05474.x","article-title":"Somatostatin suppression of meningioma cell proliferation in\u00a0vitro","volume":"75","author":"Kunert-Radek","year":"1987","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1227\/00006123-198906000-00001","article-title":"Insulin and insulin-like growth factor I in brain tumors: binding and in\u00a0vitro effects","volume":"24","author":"Glick","year":"1989","journal-title":"Neurosurgery"},{"issue":"8","key":"10.1016\/j.nec.2023.02.014_bib33","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/ijc.23737","article-title":"Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel","volume":"123","author":"Tichomirowa","year":"2008","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00701-019-03872-x","article-title":"Fluorescence imaging of meningioma cells with somatostatin receptor ligands: an in\u00a0vitro study","volume":"161","author":"Linsler","year":"2019","journal-title":"Acta Neurochir"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00691065","article-title":"Flow-through cytometry of meningiomas and cultured meningioma cells","volume":"44","author":"Kajikawa","year":"1978","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib36","first-page":"588","article-title":"DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates","volume":"66","author":"Ironside","year":"1987","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/nan.12571","article-title":"Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression","volume":"46","author":"Kim","year":"2020","journal-title":"Neuropath Appl Neuro"},{"key":"10.1016\/j.nec.2023.02.014_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2016.12.004","article-title":"Receptor tyrosine kinase inhibition by regorafenib\/sorafenib inhibits growth and invasion of meningioma cells","volume":"73","author":"Tuchen","year":"2017","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/172460089801300104","article-title":"Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins pS2 and cathepsin-D and influence of epidermal growth factor, Forskolin and phorbol ester in\u00a0vitro","volume":"13","author":"Koehorst","year":"1998","journal-title":"Int J Biol Markers"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1227\/00006123-199502000-00017","article-title":"In\u00a0vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists","volume":"36","author":"Jensen","year":"1995","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1227\/01.NEU.0000245597.46581.FB","article-title":"Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in\u00a0vivo and in\u00a0vitro","volume":"59","author":"Ragel","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nec.2023.02.014_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jocn.2021.10.035","article-title":"Establishment and characterization of meningioma patient-derived organoid","volume":"94","author":"Chan","year":"2021","journal-title":"J\u00a0Clin Neurosci"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib43","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1038\/s41467-020-18582-7","article-title":"Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma","volume":"11","author":"Magill","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/02688690120072487","article-title":"Establishment of primary human meningiomas as subcutaneous xenografts in mice","volume":"15","author":"Malham","year":"2001","journal-title":"Brit J Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1750-3639.2007.00109.x","article-title":"An orthotopic skull base model of malignant meningioma","volume":"18","author":"Baia","year":"2008","journal-title":"Brain Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.nec.2023.02.014_bib46","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.21037\/cco.2017.05.03","article-title":"Animal models of meningiomas","volume":"6","author":"Mawrin","year":"2017","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3181\/00379727-155-39750","article-title":"Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice","volume":"155","author":"Rana","year":"1977","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00006123-199801000-00027","article-title":"Matrigel augments xenograft transplantation of meningioma cells into athymic mice","volume":"42","author":"Jensen","year":"1998","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib49","first-page":"306","article-title":"Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth","volume":"92","author":"McCutcheon","year":"2000","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ame2.12050","article-title":"Orthotopic induction of CH157MN convexity and skull base meningiomas into nude mice using stereotactic surgery and MRI characterization","volume":"2","author":"La Cava","year":"2019","journal-title":"Animal Model Exp Med"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00701-012-1534-7","article-title":"Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice","volume":"155","author":"Friedrich","year":"2013","journal-title":"Acta Neurochir"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.neo.7900243","article-title":"The treatment of malignant meningioma with verotoxin","volume":"4","author":"Salhia","year":"2002","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib53","first-page":"1353","article-title":"RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth","volume":"28","author":"Kondraganti","year":"2006","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib54","first-page":"304","article-title":"A\u00a0novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells","volume":"108","author":"Ragel","year":"2008","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib55","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-12-1904","article-title":"mTORC1 inhibitors suppress meningioma growth in mouse models","volume":"19","author":"Pachow","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib56","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/neuonc\/not007","article-title":"Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model","volume":"15","author":"Iwami","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nec.2023.02.014_bib57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.wneu.2015.09.060","article-title":"Combined hydroxyurea and verapamil in the clinical treatment of refractory meningioma: human and orthotopic xenograft studies","volume":"86","author":"Karsy","year":"2016","journal-title":"World Neurosurg"},{"issue":"11","key":"10.1016\/j.nec.2023.02.014_bib58","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s12094-020-02341-7","article-title":"Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations","volume":"22","author":"Das","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.nec.2023.02.014_bib59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2017.11.035","article-title":"LB-100, a novel protein phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation","volume":"415","author":"Ho","year":"2018","journal-title":"Cancer Lett"},{"issue":"Suppl 5","key":"10.1016\/j.nec.2023.02.014_bib60","doi-asserted-by":"crossref","first-page":"S900","DOI":"10.21037\/tcr.2017.06.19","article-title":"Genetically engineered mouse models for studying radiation biology","volume":"6","author":"Castle","year":"2017","journal-title":"Transl Cancer Res"},{"issue":"9","key":"10.1016\/j.nec.2023.02.014_bib61","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.226302","article-title":"Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse","volume":"16","author":"Kalamarides","year":"2002","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1750-3639.2007.00105.x","article-title":"Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations","volume":"18","author":"Kalamarides","year":"2008","journal-title":"Brain Pathol"},{"issue":"20","key":"10.1016\/j.nec.2023.02.014_bib63","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/onc.2010.609","article-title":"Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes","volume":"30","author":"Kalamarides","year":"2011","journal-title":"Oncogene"},{"issue":"32","key":"10.1016\/j.nec.2023.02.014_bib64","doi-asserted-by":"crossref","first-page":"32713","DOI":"10.18632\/oncotarget.5296","article-title":"PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss","volume":"6","author":"Peyre","year":"2015","journal-title":"Oncotarget"},{"issue":"36","key":"10.1016\/j.nec.2023.02.014_bib65","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41388-018-0328-7","article-title":"Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation","volume":"37","author":"Boetto","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.nec.2023.02.014_bib66","doi-asserted-by":"crossref","first-page":"116553","DOI":"10.1016\/j.jns.2019.116553","article-title":"Loss of PTPRJ\/DEP-1 enhances NF2\/Merlin-dependent meningioma development","volume":"408","author":"Waldt","year":"2020","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00148394","article-title":"Arachidonic acid metabolic profiles in human meningiomas and gliomas","volume":"5","author":"Castellil","year":"1987","journal-title":"J\u00a0Neuro Oncol"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib68","first-page":"940","article-title":"Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors","volume":"112","author":"Lah","year":"2010","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0090-3019(92)90151-C","article-title":"Invasiveness in in\u00a0vitro and clinical evaluation of meningiomas","volume":"37","author":"de Ridder","year":"1992","journal-title":"Surg Neurol"},{"issue":"9","key":"10.1016\/j.nec.2023.02.014_bib70","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/neuonc\/nor072","article-title":"AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas","volume":"13","author":"Bush","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nec.2023.02.014_bib71","first-page":"1","article-title":"Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda","author":"Kumar","year":"2022","journal-title":"J\u00a0Ambient Intell Humaniz Comput"},{"key":"10.1016\/j.nec.2023.02.014_bib72","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1016\/j.wneu.2022.04.034","article-title":"A\u00a0predictive nomogram for atypical meningioma based on preoperative magnetic resonance imaging and routine blood tests","volume":"163","author":"Lin","year":"2022","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib73","first-page":"281","article-title":"Presurgical differentiation between malignant haemangiopericytoma and angiomatous meningioma by a radiomics approach based on texture analysis","volume":"46","author":"Li","year":"2019","journal-title":"J\u00a0Neuroradiol"},{"key":"10.1016\/j.nec.2023.02.014_bib74","doi-asserted-by":"crossref","first-page":"105539","DOI":"10.1016\/j.compbiomed.2022.105539","article-title":"A\u00a0classification of MRI brain tumor based on two stage feature level ensemble of deep CNN models","volume":"146","author":"Aurna","year":"2022","journal-title":"Comput Biol Med"},{"issue":"7","key":"10.1016\/j.nec.2023.02.014_bib75","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00234-022-02894-0","article-title":"A\u00a0deep learning radiomics model may help to improve the prediction performance of preoperative grading in meningioma","volume":"64","author":"Yang","year":"2022","journal-title":"Neuroradiology"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib76","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/s41598-022-07859-0","article-title":"Automatic differentiation of grade I and II meningiomas on magnetic resonance image using an asymmetric convolutional neural network","volume":"12","author":"Vassantachart","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib77","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/XST-200644","article-title":"Automatic detection of the meningioma tumor firmness in MRI images","volume":"28","author":"AlKubeyyer","year":"2020","journal-title":"J\u00a0X Ray Sci Technol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","article-title":"Current treatment options for meningioma","volume":"18","author":"Apra","year":"2018","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"10.1016\/j.nec.2023.02.014_bib79","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1007\/s00330-018-5830-3","article-title":"Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging","volume":"29","author":"Park","year":"2019","journal-title":"Eur Radiol"},{"issue":"12","key":"10.1016\/j.nec.2023.02.014_bib80","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00234-021-02813-9","article-title":"Radiomics, machine learning, and artificial intelligence: what the neuroradiologist needs to know","volume":"63","author":"Wagner","year":"2021","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib81","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib82","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13244-013-0302-4","article-title":"Magnetic resonance imaging of meningiomas: a pictorial review","volume":"5","author":"Watts","year":"2014","journal-title":"Insights Imaging"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nec.2015.11.004","article-title":"Advanced imaging of intracranial meningiomas","volume":"27","author":"Tamrazi","year":"2016","journal-title":"Neurosurg Clin N Am"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib84","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1038\/s41598-022-10956-9","article-title":"Cycle-consistent adversarial networks improves generalizability of radiomics model in grading meningiomas on external validation","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00330-018-5595-8","article-title":"Fully automated detection and segmentation of meningiomas using deep learning on routine multiparametric MRI","volume":"29","author":"Laukamp","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib86","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00330-018-5632-7","article-title":"The diagnostic value of texture analysis in predicting WHO grades of meningiomas based on ADC maps: an attempt using decision tree and decision forest","volume":"29","author":"Lu","year":"2019","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nec.2015.11.007","article-title":"Predicting meningioma consistency on preoperative neuroimaging studies","volume":"27","author":"Shiroishi","year":"2016","journal-title":"Neurosurg Clin N Am"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib88","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2013.8.FOCUS13274","article-title":"A\u00a0proposed grading system for standardizing tumor consistency of intracranial meningiomas","volume":"35","author":"Zada","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"10","key":"10.1016\/j.nec.2023.02.014_bib89","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1007\/s00330-022-08749-9","article-title":"Deep learning-based automatic segmentation of meningioma from multiparametric MRI for preoperative meningioma differentiation using radiomic features: a multicentre study","volume":"32","author":"Chen","year":"2022","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib90","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/j.crad.2022.01.039","article-title":"Comparison of different radiomic models based on enhanced T1-weighted images to predict the meningioma grade","volume":"77","author":"Duan","year":"2022","journal-title":"Clin Radiol"},{"issue":"9","key":"10.1016\/j.nec.2023.02.014_bib91","doi-asserted-by":"crossref","first-page":"e0204161","DOI":"10.1371\/journal.pone.0204161","article-title":"Preoperative and postoperative prediction of long-term meningioma outcomes","volume":"13","author":"Gennatas","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib92","doi-asserted-by":"crossref","first-page":"e0232639","DOI":"10.1371\/journal.pone.0232639","article-title":"Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy","volume":"15","author":"Keek","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.nec.2023.02.014_bib93","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3389\/fonc.2020.01398","article-title":"Development and validation of a radiomics nomogram model for predicting postoperative recurrence in patients with esophageal squamous cell cancer who achieved pCR after neoadjuvant chemoradiotherapy followed by surgery","volume":"10","author":"Qiu","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib94","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11060-018-2813-9","article-title":"Salvage therapy outcomes for atypical meningioma","volume":"138","author":"Chen","year":"2018","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.nec.2023.02.014_bib95","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3389\/fonc.2019.01031","article-title":"Circulating tumor biomarkers in meningiomas reveal a signature of equilibrium between tumor growth and immune modulation","volume":"9","author":"Erkan","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.nec.2023.02.014_bib96","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3389\/fonc.2020.01144","article-title":"Recurrence\/regrowth in grade I meningioma: how to predict?","volume":"10","author":"de Carvalho","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib97","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/07357907.2020.1773844","article-title":"In\u00a0vitro effect of dovitinib (TKI258), a multi-target angiokinase inhibitor on aggressive meningioma cells","volume":"38","author":"Das","year":"2020","journal-title":"Cancer Invest"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib98","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0360-3016(97)00018-7","article-title":"High PCNA index in meningiomas resistant to radiation therapy","volume":"38","author":"Colvett","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib99","first-page":"vdab148","article-title":"Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax","volume":"3","author":"Yamamoto","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12035-016-9763-z","article-title":"RAS promotes proliferation and resistances to apoptosis in meningioma","volume":"54","author":"Jiang","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib101","first-page":"809","article-title":"Radiation-inducible silencing of uPA and uPAR in\u00a0vitro and in\u00a0vivo in meningioma","volume":"36","author":"Rao Gogineni","year":"2010","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib102","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1593\/neo.121334","article-title":"Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells","volume":"15","author":"Velpula","year":"2013","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.4916","article-title":"Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia","volume":"242","author":"Gauchotte","year":"2017","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.nec.2023.02.014_bib104","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/neuonc\/noab015","article-title":"Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma","volume":"23","author":"Yamamoto","year":"2021","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib105","doi-asserted-by":"crossref","first-page":"e0125661","DOI":"10.1371\/journal.pone.0125661","article-title":"Overexpression of RLIP76 required for proliferation in meningioma is associated with recurrence","volume":"10","author":"Fan","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib106","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbrc.2015.03.038","article-title":"MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma","volume":"460","author":"Wang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nec.2023.02.014_bib107","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/j.wneu.2021.04.005","article-title":"Effects of the tight junction protein CLDN6 on cell migration and invasion in high-grade meningioma","volume":"151","author":"Yang","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.nec.2023.02.014_bib108","doi-asserted-by":"crossref","first-page":"102941","DOI":"10.1016\/j.ebiom.2020.102941","article-title":"GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma","volume":"59","author":"Negroni","year":"2020","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.nec.2023.02.014_bib109","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/neuonc\/noy104","article-title":"TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma","volume":"20","author":"Spiegl-Kreinecker","year":"2018","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-12-1888","article-title":"Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth","volume":"73","author":"Burns","year":"2013","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.nec.2023.02.014_bib111","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cellsig.2011.03.011","article-title":"Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells in meningioma","volume":"23","author":"Nalla","year":"2011","journal-title":"Cell Signal"},{"issue":"10","key":"10.1016\/j.nec.2023.02.014_bib112","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/onc.2012.155","article-title":"Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas","volume":"32","author":"Liu","year":"2013","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib113","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jocn.2014.10.030","article-title":"MKP-3 regulates PDGF-BB effects and MAPK activation in meningioma cells","volume":"22","author":"Johnson","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40478-020-00912-x","article-title":"KLF4(K409Q)-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment","volume":"8","author":"von Spreckelsen","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib115","first-page":"315","article-title":"KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas","volume":"9","author":"Tang","year":"2017","journal-title":"J\u00a0Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib116","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-011-0705-3","article-title":"Identification of CD105 (endoglin)-positive stem-like cells in rhabdoid meningioma","volume":"106","author":"Hu","year":"2012","journal-title":"J\u00a0Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib117","first-page":"440","article-title":"Expression of the JAK and STAT superfamilies in human meningiomas","volume":"91","author":"Magrassi","year":"1999","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib118","first-page":"658","article-title":"Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas","volume":"97","author":"Jensen","year":"2002","journal-title":"J\u00a0Neurosurg"},{"issue":"7","key":"10.1016\/j.nec.2023.02.014_bib119","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/neuonc\/not028","article-title":"Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma","volume":"15","author":"Kanno","year":"2013","journal-title":"Neuro Oncol"},{"issue":"21","key":"10.1016\/j.nec.2023.02.014_bib120","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.00332-09","article-title":"Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway","volume":"29","author":"Saydam","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.nec.2023.02.014_bib121","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1472-6882-13-303","article-title":"Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis","volume":"13","author":"Johnson","year":"2013","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"10.1016\/j.nec.2023.02.014_bib122","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00432-014-1683-6","article-title":"Re-evaluation of cytostatic therapies for meningiomas in\u00a0vitro","volume":"140","author":"Wilisch-Neumann","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"8\u20139","key":"10.1016\/j.nec.2023.02.014_bib123","first-page":"727","article-title":"[The molecular genetics of meningiomas and genotypic\/phenotypic correlations]","volume":"159","author":"Dezamis","year":"2003","journal-title":"Rev Neurol (Paris)"},{"issue":"3B","key":"10.1016\/j.nec.2023.02.014_bib124","first-page":"2295","article-title":"Telomerase activity and hTERT protein expression in meningiomas: an analysis in\u00a0vivo versus in\u00a0vitro","volume":"26","author":"Maes","year":"2006","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00406574","article-title":"Karyotypic variations in human meningioma cell cultures under different in\u00a0vitro conditions","volume":"93","author":"Zankl","year":"1979","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib126","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.surneu.2007.06.031","article-title":"A\u00a0comparison of the cell lines used in meningioma research","volume":"70","author":"Ragel","year":"2008","journal-title":"Surg Neurol"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib127","first-page":"420","article-title":"Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy","volume":"55","author":"Florian","year":"1995","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.nec.2023.02.014_bib128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00441-007-0512-5","article-title":"Characterization of a novel type of adherens junction in meningiomas and the derived cell line HBL-52","volume":"331","author":"Akat","year":"2008","journal-title":"Cell Tissue Res"},{"issue":"5","key":"10.1016\/j.nec.2023.02.014_bib129","first-page":"864","article-title":"Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF","volume":"82","author":"Tsai","year":"1995","journal-title":"J\u00a0Neurosurg"},{"issue":"11","key":"10.1016\/j.nec.2023.02.014_bib130","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/1097-0142(19891201)64:11<2243::AID-CNCR2820641110>3.0.CO;2-S","article-title":"Establishment of a human malignant meningioma cell line with amplifiedc-myc oncogene","volume":"64","author":"Tanaka","year":"1989","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib131","first-page":"25","article-title":"Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in\u00a0vitro and in\u00a0vivo in a malignant meningioma cell line","volume":"29","author":"Kondraganti","year":"2006","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib132","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1750-3639.2010.00464.x","article-title":"Loss of the protein-tyrosine phosphatase DEP-1\/PTPRJ drives meningioma cell motility","volume":"21","author":"Petermann","year":"2011","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.nec.2023.02.014_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2011.12.009","article-title":"Comparative morphological and immunohistochemical study of human meningioma after intracranial transplantation into nude mice","volume":"205","author":"Friedrich","year":"2012","journal-title":"J\u00a0Neurosci Methods"},{"issue":"19","key":"10.1016\/j.nec.2023.02.014_bib134","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1158\/1078-0432.CCR-12-0299","article-title":"The integrin inhibitor cilengitide affects meningioma cell motility and invasion","volume":"19","author":"Wilisch-Neumann","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.nec.2023.02.014_bib135","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.18632\/oncotarget.2810","article-title":"Group I Paks as therapeutic targets in NF2-deficient meningioma","volume":"6","author":"Chow","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.nec.2023.02.014_bib136","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12967-015-0596-8","article-title":"Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1","volume":"13","author":"Michelhaugh","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"9","key":"10.1016\/j.nec.2023.02.014_bib137","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/neuonc\/now031","article-title":"A\u00a0new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus","volume":"18","author":"Nigim","year":"2016","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2023.02.014_bib138","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11060-018-03009-7","article-title":"Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma","volume":"140","author":"Skibinski","year":"2018","journal-title":"J\u00a0Neuro Oncol"},{"issue":"7","key":"10.1016\/j.nec.2023.02.014_bib139","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s12094-019-02240-6","article-title":"Ganoderic acid A\/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth","volume":"22","author":"Das","year":"2020","journal-title":"Clin Transl Oncol"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368023000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368023000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:03:55Z","timestamp":1760904235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368023000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1042368023000268"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2023.02.014","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling Meningiomas","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2023.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}